Opposite effects of CCK(B) agonists in grooming behaviour in rats: further evidence for two CCK(B) subsites (Q41954727)

14 October 2017

Opposite effects of CCK(B) agonists in grooming behaviour in rats: further evidence for two CCK(B) subsites (English)

1 reference

14 October 2017

Ladurelle N

1

1 reference

14 October 2017

Sebret A

2

1 reference

14 October 2017

Garbay C

3

1 reference

14 October 2017

Roques BP

4

1 reference

14 October 2017

Daugé V

5

1 reference

14 October 2017

language of work or name

English

0 references

publication date

1 July 1998

1 reference

British Journal of Pharmacology

14 October 2017

1 reference

14 October 2017

124

1 reference

14 October 2017

6

1 reference

14 October 2017

1091-1098

1 reference

The panicogenic effects of cholecystokinin-tetrapeptide are antagonized by L-365,260, a central cholecystokinin receptor antagonist, in patients with panic disorder

14 October 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701933

Analysis of variation in L-365,260 competition curves in radioligand binding assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701933

A three-state receptor model of agonist action

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701933

Failure of CCK receptor ligands to modify anxiety-related behavioural suppression in an operant conflict paradigm in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701933

7 January 2021

Enzyme-resistant CCK analogs with high affinities for central receptors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701933

7 January 2021

Cyclic cholecystokinin analogues with high selectivity for central receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701933

7 January 2021

Anxiolytic effects of CCK-B antagonists

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701933

7 January 2021

Cholecystokinin-dopamine interactions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701933

7 January 2021

Biological actions of cholecystokinin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701933

7 January 2021

The selective CCK-B agonist, BC 264 injected in the antero-lateral part of the nucleus accumbens, reduces the spontaneous alternation behaviour of rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701933

7 January 2021

Heterogeneity of CCK-B receptors involved in animal models of anxiety

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701933

7 January 2021

Occurrence of two cholecystokinin binding sites in guinea-pig brain cortex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701933

7 January 2021

Characterization of [3H] CCK4 binding sites in mouse and rat brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701933

7 January 2021

Characterization and visualization of cholecystokinin receptors in rat brain using [3H]pentagastrin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701933

7 January 2021

CCK in animal and human research on anxiety

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701933

7 January 2021

Autoradiographic localization and biochemical characterization of peripheral type CCK receptors in rat CNS using highly selective nonpeptide CCK antagonists.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701933

7 January 2021

Evidence for coexistence of dopamine and CCK in meso-limbic neurones

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701933

7 January 2021

Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701933

7 January 2021

Bombesin and ceruletide-induced grooming and inhibition of ingestion in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701933

7 January 2021

The CCK-B agonist, BC264, increases dopamine in the nucleus accumbens and facilitates motivation and attention after intraperitoneal injection in rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701933

7 January 2021

A new potent and selective non-peptide gastrin antagonist and brain cholecystokinin receptor (CCK-B) ligand: L-365,260

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701933

7 January 2021

Effects of selective drugs for dopaminergic D1 and D2 receptors on conditioned locomotion in rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701933

7 January 2021

Dopaminergic behaviour stereospecific promoted by the D1 agonist R-SK & F 38393 and selectively blocked by the D1 antagonist SCH 23390

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701933

7 January 2021

The effects of anxiolytics and other agents on rat grooming behavior

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701933

7 January 2021

Two brain cholecystokinin receptors: implications for behavioral actions.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701933

7 January 2021

Autoradiography of CCK receptors in the rat brain using [(3)H]Boc[Nle(28)(31)]CCK(27)-(33) and [(125)I]bolton-hunter CCK(8). Functional significance of subregional distributions.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701933

7 January 2021

'Anxiolytic' effect of CCK-antagonists on plus-maze behavior in mice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701933

7 January 2021

Effects of BOC-CCK-4 and L 365.260 on cortical 5-HT release in guinea-pigs on exposure to the elevated plus maze

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701933

7 January 2021

Stimulation of delta-opioid receptors reduces the in vivo binding of the cholecystokinin (CCK)-B-selective agonist [3H]pBC 264: evidence for a physiological regulation of CCKergic systems by endogenous enkephalins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701933

7 January 2021

Reversal of antidepressant action by dopamine antagonists in an animal model of depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701933

7 January 2021

Evidence for an involvement of the brain cholecystokinin B receptor in anxiety

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701933

7 January 2021

Differential effects of dopamine D1 and D2 agonists and antagonists on velocity of movement, rearing and grooming in the mouse. Implications for the roles of D1 and D2 receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701933

7 January 2021

Direct demonstration of three different states of the pancreatic cholecystokinin receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701933

7 January 2021

Brain and gastrointestinal cholecystokinin receptor family: structure and functional expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJP.0701933

7 January 2021

Identifiers

DOI

10.1038/SJ.BJP.0701933

1 reference

14 October 2017

1 reference

14 October 2017

PubMed publication ID

9720778

1 reference